Literature DB >> 17526682

Routine antenatal HIV testing: the responses and perceptions of pregnant women and the viability of informed consent. A qualitative study.

Paquita de Zulueta1, Mary Boulton.   

Abstract

This qualitative cross-sectional survey, undertaken in the antenatal booking clinics of a hospital in central London, explores pregnant women's responses to routine HIV testing, examines their reasons for declining or accepting the test, and assesses how far their responses fulfil standard criteria for informed consent. Of the 32 women interviewed, only 10 participants were prepared for HIV testing at their booking interview. None of the women viewed themselves as being particularly at risk for HIV infection. The minority (n = 6) of the participants who declined testing differed from those who accepted, by interpreting test acceptance as risky behaviour, privileging the negative outcomes of HIV positivity and expressing an inability to cope with these, should they occur. Troublingly, only a minority of women (n = 9) had a broad understanding of the rationale for the test, and none fulfilled the standard criteria for informed consent. This study suggests that, although routine screening combined with professional recommendation may be successful in increasing uptake, this may be at the cost of eroding informed consent. Protecting third parties (notably fetuses) from a preventable disease may outweigh the moral duty of respecting autonomy, enshrined in Western bioethical tradition. Nevertheless, such a policy should be made transparent, debated in the public domain and negotiated with women seeking antenatal care.

Entities:  

Mesh:

Year:  2007        PMID: 17526682      PMCID: PMC2598283          DOI: 10.1136/jme.2006.015750

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  26 in total

1.  Reducing vertical transmission of HIV in the UK.

Authors:  A Nicoll; C Peckham
Journal:  BMJ       Date:  1999-11-06

2.  Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1.

Authors:  L Mandelbrot; A Landreau-Mascaro; C Rekacewicz; A Berrebi; J L Bénifla; M Burgard; E Lachassine; B Barret; M L Chaix; A Bongain; N Ciraru-Vigneron; C Crenn-Hébert; J F Delfraissy; C Rouzioux; M J Mayaux; S Blanche
Journal:  JAMA       Date:  2001-04-25       Impact factor: 56.272

3.  HIV screening in pregnancy: what women think.

Authors:  A Katz
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2001 Mar-Apr

Review 4.  Presenting risk information--a review of the effects of "framing" and other manipulations on patient outcomes.

Authors:  A Edwards; G Elwyn; J Covey; E Matthews; R Pill
Journal:  J Health Commun       Date:  2001 Jan-Mar

Review 5.  HIV testing of pregnant women--what is needed to protect positive women's needs and rights?

Authors:  Maria de Bruyn; Susan Paxton
Journal:  Sex Health       Date:  2005       Impact factor: 2.706

6.  Vertical transmission rates for HIV in the British Isles: estimates based on surveillance data.

Authors:  T Duong; A E Ades; D M Gibb; P A Tookey; J Masters
Journal:  BMJ       Date:  1999-11-06

7.  Consent and antenatal HIV testing: the limits of choice and issues of consent in HIV and AIDS.

Authors:  L Sherr; A Bergenstrom; C N Hudson
Journal:  AIDS Care       Date:  2000-06

8.  Barriers to universal prenatal HIV testing in 4 US locations in 1997.

Authors:  R A Royce; E B Walter; M I Fernandez; T E Wilson; J R Ickovics; R J Simonds
Journal:  Am J Public Health       Date:  2001-05       Impact factor: 9.308

9.  Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women.

Authors: 
Journal:  J Acquir Immune Defic Syndr       Date:  2003-04-01       Impact factor: 3.731

10.  Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers.

Authors:  Miriam C Poirier; Rao L Divi; Lena Al-Harthi; Ofelia A Olivero; Vi Nguyen; Brettania Walker; Alan L Landay; Vernon E Walker; Manhattan Charurat; William A Blattner
Journal:  J Acquir Immune Defic Syndr       Date:  2003-06-01       Impact factor: 3.731

View more
  8 in total

1.  Towards a family-centered approach to HIV treatment and care for HIV-exposed children, their mothers and their families in poorly resourced settings.

Authors:  Tamsen Jean Rochat; Ruth Bland; Hoosen Coovadia; Alan Stein; Marie-Louise Newell
Journal:  Future Virol       Date:  2011-06       Impact factor: 1.831

2.  Routine antenatal HIV testing and informed consent: an unworkable marriage?

Authors:  R Bennett
Journal:  J Med Ethics       Date:  2007-08       Impact factor: 2.903

3.  Foetal surgery and using in utero therapies to reduce the degree of disability after birth. Could it be morally defensible or even morally required?

Authors:  Constantinos Kanaris
Journal:  Med Health Care Philos       Date:  2017-03

4.  The complexity of consent: women's experiences testing for HIV at an antenatal clinic in Durban, South Africa.

Authors:  Allison K Groves; Suzanne Maman; Sibekezelo Msomi; Nduduzo Makhanya; Dhayendre Moodley
Journal:  AIDS Care       Date:  2010-05

5.  Routine prenatal HIV testing: women's concerns and their strategies for addressing concerns.

Authors:  Pamela Rothpletz-Puglia; Deborah Storm; Carolyn Burr; Deanne Samuels
Journal:  Matern Child Health J       Date:  2012-02

6.  The necessity of HIV testing in Iranian pregnant women and its ethical considerations.

Authors:  Pooneh Salari; Maryam Azizi
Journal:  J Med Ethics Hist Med       Date:  2009-01-13

7.  Impact of gender on the decision to participate in a clinical trial: a cross-sectional study.

Authors:  Lucas Lobato; Jeffrey Michael Bethony; Fernanda Bicalho Pereira; Shannon Lee Grahek; David Diemert; Maria Flávia Gazzinelli
Journal:  BMC Public Health       Date:  2014-11-06       Impact factor: 3.295

Review 8.  Ethical issues surrounding the provider initiated opt--Out prenatal HIV screening practice in Sub-Saharan Africa: a literature review.

Authors:  Luchuo Engelbert Bain; Kris Dierickx; Kristien Hens
Journal:  BMC Med Ethics       Date:  2015-10-24       Impact factor: 2.652

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.